EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis

Biplob Kumar Mohanty iD, Tomas Mikal Lind Eagan, Bernt Bøgvald Aarli, Dag Harald Skutlaberg iD, Tehmina Mustafa iD

Pathogens · 2024

DOI: 10.3390/pathogens13040344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Biplob Kumar Mohanty und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, 5020 Bergen, Norway. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Information on the management of non-tuberculous mycobacterial (NTM) lung infection and disease is scarce. The aim of this study was to investigate the trends in NTM lung infections, and the factors associated with the initiation of treatment and treatment outcomes.

Methods

A retrospective analysis was carried out on patient medical records from Haukeland University Hospital, Bergen, Norway, from 2000 to 2021.

Results

Among 154 patients with NTM lung infection, the majority (70%) were older than 65 years, and 49% had an underlying pulmonary comorbidity. The most frequently observed mycobacterial species was M. avium complex (MAC), followed by M. malmoense and M. abscessus. In total, 72 (47%) patients received antibiotic treatment. Patients with high symptom scores, aged below 65, and with MAC infection had more than three times the odds of receiving antibiotic treatment. A favourable response and culture conversion was observed in 53 of 72 (74%) patients. However, 17 (32%) of them had a relapse. Out of 82 patients who did not receive treatment, 45 (55%) had spontaneous culture conversion, and 8 (18%) of them had a relapse. No factor was identified to be significantly associated with a favourable treatment response.

Conclusion

A favourable response to treatment was seen in 74% of patients with a high relapse rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium Infections, NontuberculousNontuberculous MycobacteriaAnti-Bacterial AgentsHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomePrevalenceNorwayLung DiseasesAged, 80 and overAdult

Stichwörter der Autor:innen

mycobacterium aviumnon-tuberculous mycobacteriarelapsetreatment response

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, 5020 Bergen, Norway.
  • Department of Thoracic Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
  • Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.
  • Department of Microbiology, Haukeland University Hospital, 5021 Bergen, Norway.

ORCID-Profile: Biplob Kumar Mohanty, Dag Harald Skutlaberg, Tehmina Mustafa

Zitieren

APA

Mohanty, B. K., Eagan, T. M. L., Aarli, B. B., Skutlaberg, D. H., & Mustafa, T. (2024). Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis. Pathogens. https://doi.org/10.3390/pathogens13040344

Vancouver

Mohanty BK, Eagan TML, Aarli BB, Skutlaberg DH, Mustafa T. Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis. Pathogens. 2024. doi:10.3390/pathogens13040344

BibTeX
@article{Mohanty2024,
  author = {Mohanty, Biplob Kumar and Eagan, Tomas Mikal Lind and Aarli, Bernt Bøgvald and Skutlaberg, Dag Harald and Mustafa, Tehmina},
  title = {Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13040344}
}
Kostenlos starten →